Aalt van Dijk
Impact in
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 4
-
- Pneumonia and Respiratory Infections 2
- Co-authors
- F. T. J. Boereboom (3 shared papers)Jan Meulenbelt (3 shared papers)Geert H. Blijham (3 shared papers)Alfred D. van het Schip (2 shared papers)John M. H. de Klerk (3 shared papers)Peter P. van Rijk (2 shared papers)Tessa Ververs (2 shared papers)André Fleer (2 shared papers)
- Journals
- European Journal of Nuclear Medicine and Molecular Imaging (3 papers)Critical Care Medicine (2 papers)Therapeutic Drug Monitoring (2 papers)Biochemical Pharmacology (1 paper)International Journal of Immunopharmacology (1 paper)
- Partner nations
- NetherlandsGermanyGuinea-Bissau
In The Last Decade
Aalt van Dijk
12 papers receiving 393 citations
Peers
Comparison fields: 5 of 74
- Pharmacology 105
- Radiology, Nuclear Medicine and Imaging 109
- Emergency Medicine 33
- Nephrology 24
- Oncology 67
Countries citing papers authored by Aalt van Dijk
This map shows the geographic impact of Aalt van Dijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aalt van Dijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aalt van Dijk more than expected).
Fields of papers citing papers by Aalt van Dijk
This network shows the impact of papers produced by Aalt van Dijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aalt van Dijk. The network helps show where Aalt van Dijk may publish in the future.
Co-authors
The 25 scholars most cited alongside Aalt van Dijk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The PLACORHEN study: a double-blind, placebo-controlled, randomized radionuclide study with (186)Re-etidronate in hormone-resistant prostate cancer patients with painful bone metastases. Placebo Controlled Rhenium Study. | 2002 | 76 |
| 2 | 1994 | 65 | |
| 3 | 2000 | 61 | |
| 4 | 2001 | 45 | |
| 5 | 1999 | 42 | |
| 6 | 1990 | 36 | |
| 7 | 1998 | 28 | |
| 8 | 2001 | 24 | |
| 9 | 1993 | 18 | |
| 10 | 2000 | 12 | |
| 11 | 1992 | 10 | |
| 12 | 2000 | 4 |
About Aalt van Dijk
Aalt van Dijk is a scholar working on Pharmacology, Epidemiology, Pediatrics, Perinatology and Child Health, Radiology, Nuclear Medicine and Imaging and Analytical Chemistry, having authored 12 papers that have together received 421 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Pneumonia and Respiratory Infections (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Pesticide and Herbicide Environmental Studies (1 paper), Paraquat toxicity studies and treatments (1 paper), Epilepsy research and treatment (1 paper), Metabolism and Genetic Disorders (1 paper) and Cassava research and cyanide (1 paper). The work is most often cited by research in Pharmacology (105 citations), Radiology, Nuclear Medicine and Imaging (109 citations), Emergency Medicine (33 citations), Nephrology (24 citations) and Oncology (67 citations). Aalt van Dijk has collaborated with scholars based in Netherlands, Germany and Guinea-Bissau. Frequent co-authors include F. T. J. Boereboom, Jan Meulenbelt, Geert H. Blijham, Alfred D. van het Schip, John M. H. de Klerk, Peter P. van Rijk, Tessa Ververs, André Fleer, Peter J. Blankestijn and T.J.F. Savelkoul. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Critical Care Medicine, Therapeutic Drug Monitoring, Biochemical Pharmacology and International Journal of Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.